Late results of skin‐sparing mastectomy followed by immediate breast reconstruction
Background:
Skin‐sparing mastectomy (SSM) facilitates optimal immediate breast reconstruction (IBR) by preserving the inframammary fold and most of the breast skin. Concerns persist that SSM might increase the rate of local recurrence as the surgical approach is less extensive. Patients who had SSM and IBR over 10 years at a single institution were reviewed.
Methods:
A total of 207 consecutive women who underwent SSM and IBR from 1992 to 2001 were included in the study. The patient records were analysed retrospectively and follow‐up data were included.
Results:
Postoperative complications included native skin flap necrosis (10·1 per cent), haematoma (10·6 per cent), infection (3·4 per cent), anastomotic thrombosis (5·3 per cent) and hernia (2·6 per cent). During a mean follow‐up of 70 months, 5·8 per cent of patients with stage 0–2 disease developed a locoregional recurrence, although none of these later had a systemic recurrence. The rate of locoregional recurrence was 31 per cent (five of 16) in women with stage 3 breast cancer.
Conclusion:
SSM followed by IBR was both surgically and oncologically safe, especially for early‐stage breast cancer. Copyright © 2007 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.
Skin‐sparing mastectomy (SSM) facilitates optimal immediate breast reconstruction (IBR) by preserving the inframammary fold and most of the breast skin. Concerns persist that SSM might increase the rate of local recurrence as the surgical approach is less extensive. Patients who had SSM and IBR over 10 years at a single institution were reviewed.
Methods:
A total of 207 consecutive women who underwent SSM and IBR from 1992 to 2001 were included in the study. The patient records were analysed retrospectively and follow‐up data were included.
Results:
Postoperative complications included native skin flap necrosis (10·1 per cent), haematoma (10·6 per cent), infection (3·4 per cent), anastomotic thrombosis (5·3 per cent) and hernia (2·6 per cent). During a mean follow‐up of 70 months, 5·8 per cent of patients with stage 0–2 disease developed a locoregional recurrence, although none of these later had a systemic recurrence. The rate of locoregional recurrence was 31 per cent (five of 16) in women with stage 3 breast cancer.
Conclusion:
SSM followed by IBR was both surgically and oncologically safe, especially for early‐stage breast cancer. Copyright © 2007 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics
Document Type: Research Article
Publication date: October 1, 2007
- As of January 2010, this journal will no longer be available on IngentaConnect, please visit Wiley InterScience to arrange continued access to this content
- Access this journal at Wiley InterScience
- Ingenta Connect is not responsible for the content or availability of external websites